Related Experiment Video
Updated: Aug 25, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
The 2022 human monkeypox outbreak: Clinical review and management guidance
Mohammed Aldhaeefi1, Dhakrit Rungkitwattanakul1, Jacqueise Unonu1
1Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, Washington, DC, USA.
This review covers antiviral treatments and vaccines for monkeypox (a DNA virus). While no specific FDA-approved therapies exist, smallpox antivirals show promise for monkeypox management and prevention.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Monkeypox is a zoonotic DNA virus in the Orthopoxvirus genus.
- Case fatality rates range from 0% to 11%, with potential severe complications.
- Current management relies on supportive care and infection control.
Conclusions:
- Surveillance and detection in high-risk populations are crucial for understanding monkeypox epidemiology.
- Further research into targeted monkeypox therapies is warranted.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Steps in Outbreak Investigation
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

